why choose us

First received: August 03, 2023

Clinical Trial: A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Migraine

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Zavegepant Intranasal (IN) for the Acute Treatment of Migraine in Asian Adults

Brief Summary: The purpose of this study is to learn how safe and effective zavegepant is compared to placebo in the acute treatment of migraine in Asian adults.Migraine is a very painful headache with other associated symptoms such as nausea, photophobia and phonophobia.A placebo is a harmless treatment that has no medical effect.This study is seeking for participants who:have at least 1 year of migraine history before entering the study.have 2 to 8 migraine headache attacks of moderate or severe intensity in each of the 3…

Read more